[1] |
CRISAFULLI S, SULTANA J, FONTANA A, et al. Global epidemiology of Duchenne muscular dystrophy:an updated systematic review and meta-analysis[J]. Orphanet J Rare Dis, 2020, 15(1):141.
DOI
|
[2] |
GILIBERTO F, RADIC C P, LUCE L, et al. Symptomatic female carriers of Duchenne muscular dystrophy (DMD):genetic and clinical characterization[J]. J Neurol Sci, 2014, 336(1-2):36-41.
DOI
URL
|
[3] |
QUIJANO-ROY S, HABERLOVA J, CASTIGLIONI C, et al. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies:a large international cohort[J]. J Neurol, 2022, 269(5):2414-2429.
DOI
|
[4] |
赵炜, 姜楠, 李朔, 等. 假性肥大型肌营养不良症的遗传学分析及产前诊断[J]. 中华妇产科杂志, 2019, 54(4):6.
|
[5] |
WANG J, ZHANG W, JIANG H, et al. Mutations in HFM1 in recessive primary ovarian insufficiency[J]. N Engl J Med, 2014, 370(10):972-974.
DOI
URL
|
[6] |
北京医学会罕见病分会, 北京医学会神经内科分会神经肌肉病学组, 中国肌营养不良协作组. Duchenne型肌营养不良多学科管理专家共识[J]. 中华医学杂志, 2018, 98(35):12.
|
[7] |
RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
|
[8] |
MUNTONI F, TORELLI S, FERLINI A. Dystrophin and mutations:one gene,several proteins,multiple phenotypes[J]. Lancet Neurol, 2003, 2(12):731-740.
DOI
URL
|
[9] |
PATEL K M, BHATT A D, SHAH K, et al. Molecular diagnosis of muscular dystrophy patients in western Indian population:a comprehensive mutation analysis using amplicon sequencing[J]. Front Genet, 2021, 12:770350.
DOI
URL
|
[10] |
NERI M, ROSSI R, TRABANELLI C, et al. The genetic landscape of dystrophin mutations in Italy:a nationwide study[J]. Front Genet, 2020, 11:131.
DOI
URL
|
[11] |
WHITE S J, DEN DUNNEN J T. Copy number variation in the genome;the human DMD gene as an example[J]. Cytogenet Genome Res, 2006, 115(3-4):240-246.
DOI
URL
|
[12] |
LI X, ZHAO L, ZHOU S, et al. A comprehensive database of Duchenne and Becker muscular dystrophy patients(0-18 years old) in East China[J]. Orphanet J Rare Dis, 2015, 10:5.
DOI
URL
|
[13] |
OUDET C, HANAUER A, CLEMENS P, et al. Two hot spots of recombination in the DMD gene correlate with the deletion prone regions[J]. Hum Mol Genet, 1992, 1(8):599-603.
DOI
URL
|
[14] |
FROMER M, MORAN J L, CHAMBERT K, et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth[J]. Am J Hum Genet, 2012, 91(4):597-607.
DOI
PMID
|
[15] |
HU X, LI N, XU Y, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country:the China experience[J]. Genet Med, 2018, 20(9):1045-1053.
|
[16] |
SALMANINEJAD A, JAFARI ABARGHAN Y, BOZORG QOMI S, et al. Common therapeutic advances for Duchenne muscular dystrophy(DMD)[J]. Int J Neurosci, 2021, 131(4):370-389.
DOI
URL
|
[17] |
李媛媛, 刘卓, 欧阳胜荣, 等. 以转氨酶升高为首发表现的假肥大型肌营养不良临床分析[J]. 中华实用儿科临床杂志, 2017, 32(24):5.
|
[18] |
NALLAMILLI B R R, CHAKRAVORTY S, KESARI A, et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4 656 patients[J]. Ann Clin Transl Neurol, 2018, 5(12):1574-1587.
DOI
URL
|
[19] |
OLIVEIRA J, GRUBER A, CARDOSO M, et al. LAMA2 gene mutation update:toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes[J]. Hum Mutat, 2018, 39(10):1314-1337.
DOI
URL
|
[20] |
SILVA T H D, ANEQUINI I P, FÁVERO F M, et al. Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy[J]. Arq Neuropsiquiatr, 2020, 78(3):143-148.
DOI
URL
|
[21] |
KAMAKURA K, KAWAI M, ARAHATA K, et al. A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms[J]. J Neurol, 1990, 237(8):483-485.
PMID
|
[22] |
HOOGERWAARD E M, VAN DER WOUW P A, Wilde A A, et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy[J]. Neuromuscul Disord, 1999, 9(5):347-351.
DOI
URL
|
[23] |
PANNING B. X-chromosome inactivation:the molecular basis of silencing[J]. J Biol, 2008, 7(8):30.
DOI
URL
|
[24] |
VIGGIANO E, PICILLO E, CIRILLO A, et al. Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers,non-manifesting carriers and related daughters[J]. Clin Genet, 2013, 84(3):265-270.
DOI
URL
|
[25] |
VIGGIANO E, ERGOLI M, PICILLO E, et al. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy[J]. Hum Genet, 2016, 135(7):685-698.
DOI
PMID
|